Deepinder Goyal’s longevity project, Continue, is exploring whether gravity plays a major role in age-related decline by ...

A long-term follow-up study from a consortium of six European countries, coordinated by the department of Surgery of the ...

When James Scott Wilson was rushed to the hospital in 2023 with end-stage liver failure, he knew his time was running out. As ...

Goyal said he hopes the questions “spark global research” far beyond what he personally can fund — adding that he plans to ...

New collaboration expands access to more than 50 online healthcare and technology certification programs, creating flexible, ...

At AAPS PharmSci 360 2025, Elly Zhou says digital twins helped forecast the effects of drugs on human drugs via a digital control arm.

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue ...

Ahead of EBR's official October 1 Us launch of its Wise device, surgeons have already used the heart tool in 12 procedures.

Ex vivo lung perfusion (EVLP) provides a platform for testing therapies but faces challenges in standardizing drug evaluation. At AAPS PharmSci 360, Xuanzi Zhou says digital twins accurately predict ...

(Alliance News) - Imaging Biometrics Ltd on Thursday noted the use of its Functional Tumor Burden mapping technology in a glioblastoma clinical trial at Cooper University's MD Anderson Cancer Center.

NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers today ...

A university spinout has been acquired in a record-breaking deal. OrganOx, an Oxford University spinout that has ...